Funds and ETFs IM Cannabis Corp.

Equities

IMCC

CA44969Q3070

Pharmaceuticals

Delayed Canadian Securities Exchange 03:59:59 2024-03-28 pm EDT 5-day change 1st Jan Change
0.63 CAD 0.00% Intraday chart for IM Cannabis Corp. +63.64% +36.96%

ETFs positioned on IM Cannabis Corp.

Name Weight AuM 1st Jan change Investor Rating
0.05% 29 M€ +35.13% -
IM Cannabis Corp. is a Canada-based medical cannabis company. The Company operates in Israel through its commercial relationship with Focus Medical Herbs Ltd. (Focus Medical), which held a cultivation license to breed, grow and supply medical cannabis products in Israel. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centres and logistical hubs in Israel. The Company operates through Adjupharm GmbH in Europe, which is a medical cannabis producer and distributor with wholesale, narcotics handling, manufacturing, procurement, storage, and distribution licenses granted by German regulatory authorities that allow for import/export capability with requisite permits. The Company operates through Trichome and its subsidiaries Trichome JWC Acquisition Corp. and MYM Nutraceuticals Inc., where it cultivates and processes cannabis for the adult-use market at its Ontario and Nova Scotia facilities under the WAGNERS and Highland Grow brands.
More about the company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.63 CAD
Average target price
3.45 CAD
Spread / Average Target
+447.62%
Consensus

Quarterly revenue - Rate of surprise